Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review
Background: Although remdesivir treatment is widely used during the pandemic coronavirus disease 2019 (COVID-19), there is scarce evidence regarding its cardiac side effects. Case presentation: We report the case of a 36-year-old male hospitalized due to severe COVID-19 symptoms. He presented with a...
Main Authors: | Fotios Barkas, Chrysoula-Paraskevi Styla, Aris Bechlioulis, Haralampos Milionis, Evangelos Liberopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/8/2/18 |
Similar Items
-
Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports
by: Alaaeldin Abdelmajid, et al.
Published: (2021-01-01) -
Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease
by: Jomel Patrick Jacinto, DO, et al.
Published: (2021-08-01) -
Marked Sinus Bradycardia Associated With Remdesivir in COVID-19
by: James C. Gubitosa, DO, et al.
Published: (2020-11-01) -
The journey of remdesivir: from Ebola to COVID-19
by: Joe Pardo, et al.
Published: (2020-05-01) -
Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
by: Rameez Hassan Pirzada, et al.
Published: (2021-04-01)